PhaseBio Pharmaceuticals Inc
Pharmaceutical company · Malvern, Pennsylvania, United States
PhaseBio Pharmaceuticals Inc is a pharmaceutical company headquartered in Malvern, Pennsylvania, United States. It has received 5 US government small-business research awards (SBIR/STTR) from health agencies, $3.6 million in total, most recently in 2018. It has reported private securities offerings to the US SEC, most recently $26 million sold in a notice filed in 2018.
PhaseBio Pharmaceuticals at a glance
What does PhaseBio Pharmaceuticals do?
US government research funding
5 SBIR/STTR small-business research awards from US health agencies, $3.6 million in total (2004 to 2018). NIH funding came from the National Heart, Lung, and Blood Institute.
Private fundraising reported to the SEC
8 Form D notices; the most recent reported $26 million sold (2018).
Frequently asked questions about PhaseBio Pharmaceuticals
Where is PhaseBio Pharmaceuticals headquartered?
PhaseBio Pharmaceuticals Inc is headquartered in Malvern, Pennsylvania, United States.
What does PhaseBio Pharmaceuticals do?
PhaseBio Pharmaceuticals Inc is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Similar companies
- Galera Therapeutics, Inc.Malvern, Pennsylvania, United States
- Annovis Bio, Inc.Malvern, Pennsylvania, United States
- Venatorx Pharmaceuticals, Inc.Malvern, Pennsylvania, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.